NL1004878C2 - Ver-infrarood stralend materiaal en daarvan vervaardigd geneesmiddel en voedselprodukt alsmede een werkwijze voor het vervaardigen ervan. - Google Patents

Ver-infrarood stralend materiaal en daarvan vervaardigd geneesmiddel en voedselprodukt alsmede een werkwijze voor het vervaardigen ervan. Download PDF

Info

Publication number: NL1004878C2
Authority: NL; Netherlands
Prior art keywords: infrared radiation; sges; rock; far infrared; wavelength
Prior art date: 1995-12-25

Application number

NL1004878A

Other languages

English (en)

Dutch (nl)

Other versions

NL1004878A1 (nl

Inventor

Kozo Niwa

Kazuyuki Torii

Original Assignee

Kozo Niwa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-25

Filing date

1996-12-23

Publication date

1998-03-06

1996-12-23 Application filed by Kozo Niwa filed Critical Kozo Niwa

1997-07-02 Publication of NL1004878A1 publication Critical patent/NL1004878A1/xx

1998-03-06 Application granted granted Critical

1998-03-06 Publication of NL1004878C2 publication Critical patent/NL1004878C2/nl

Links

230000005855 radiation Effects 0.000 title claims description 42
239000000463 material Substances 0.000 title claims description 26
238000004519 manufacturing process Methods 0.000 title claims description 12
239000003814 drug Substances 0.000 title claims description 11
235000013305 food Nutrition 0.000 title claims description 7
229940079593 drug Drugs 0.000 title description 5
239000000843 powder Substances 0.000 claims description 24
239000004575 stone Substances 0.000 claims description 24
239000011435 rock Substances 0.000 claims description 14
239000004576 sand Substances 0.000 claims description 12
229910052742 iron Inorganic materials 0.000 claims description 10
238000010298 pulverizing process Methods 0.000 claims description 10
238000000227 grinding Methods 0.000 claims description 3
239000000919 ceramic Substances 0.000 description 35
210000004027 cell Anatomy 0.000 description 25
210000000440 neutrophil Anatomy 0.000 description 18
-1 lipid peroxide Chemical class 0.000 description 15
230000000694 effects Effects 0.000 description 14
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
206010028980 Neoplasm Diseases 0.000 description 12
238000002474 experimental method Methods 0.000 description 12
201000011510 cancer Diseases 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
239000000203 mixture Substances 0.000 description 9
230000009467 reduction Effects 0.000 description 9
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 8
210000004369 blood Anatomy 0.000 description 8
239000008280 blood Substances 0.000 description 8
229910052613 tourmaline Inorganic materials 0.000 description 8
229940070527 tourmaline Drugs 0.000 description 8
239000011032 tourmaline Substances 0.000 description 8
239000010438 granite Substances 0.000 description 7
208000032839 leukemia Diseases 0.000 description 7
RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 6
241000700159 Rattus Species 0.000 description 6
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
210000004698 lymphocyte Anatomy 0.000 description 6
230000035755 proliferation Effects 0.000 description 6
241000699670 Mus sp. Species 0.000 description 5
208000025747 Rheumatic disease Diseases 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 5
229910052760 oxygen Inorganic materials 0.000 description 5
239000001301 oxygen Substances 0.000 description 5
230000000552 rheumatic effect Effects 0.000 description 5
210000004881 tumor cell Anatomy 0.000 description 5
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
235000020669 docosahexaenoic acid Nutrition 0.000 description 4
229940090949 docosahexaenoic acid Drugs 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
230000005012 migration Effects 0.000 description 4
238000013508 migration Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
208000006820 Arthralgia Diseases 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
239000005662 Paraffin oil Substances 0.000 description 3
239000012980 RPMI-1640 medium Substances 0.000 description 3
239000007789 gas Substances 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
238000005259 measurement Methods 0.000 description 3
238000000034 method Methods 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
229920001817 Agar Polymers 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
PRQROPMIIGLWRP-UHFFFAOYSA-N N-formyl-methionyl-leucyl-phenylalanin Chemical compound CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-UHFFFAOYSA-N 0.000 description 2
208000003782 Raynaud disease Diseases 0.000 description 2
208000012322 Raynaud phenomenon Diseases 0.000 description 2
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
208000006268 Sarcoma 180 Diseases 0.000 description 2
206010040943 Skin Ulcer Diseases 0.000 description 2
201000009594 Systemic Scleroderma Diseases 0.000 description 2
206010042953 Systemic sclerosis Diseases 0.000 description 2
206010043540 Thromboangiitis obliterans Diseases 0.000 description 2
102000003929 Transaminases Human genes 0.000 description 2
108090000340 Transaminases Proteins 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
239000008272 agar Substances 0.000 description 2
210000001142 back Anatomy 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000035584 blastogenesis Effects 0.000 description 2
244000309466 calf Species 0.000 description 2
230000008859 change Effects 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
239000002537 cosmetic Substances 0.000 description 2
230000036541 health Effects 0.000 description 2
235000013402 health food Nutrition 0.000 description 2
239000012535 impurity Substances 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
229910052753 mercury Inorganic materials 0.000 description 2
210000005259 peripheral blood Anatomy 0.000 description 2
239000011886 peripheral blood Substances 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
230000000750 progressive effect Effects 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
206010000060 Abdominal distension Diseases 0.000 description 1
108010075031 Cytochromes c Proteins 0.000 description 1
206010012438 Dermatitis atopic Diseases 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
208000001382 Experimental Melanoma Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
229920002683 Glycosaminoglycan Polymers 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
208000008763 Mercury poisoning Diseases 0.000 description 1
206010027439 Metal poisoning Diseases 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
101100013458 Mus musculus Ftl1 gene Proteins 0.000 description 1
206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
101100093389 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) crp-7 gene Proteins 0.000 description 1
RSPISYXLHRIGJD-UHFFFAOYSA-N OOOO Chemical compound OOOO RSPISYXLHRIGJD-UHFFFAOYSA-N 0.000 description 1
206010033799 Paralysis Diseases 0.000 description 1
241000700157 Rattus norvegicus Species 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
WIGAYVXYNSVZAV-UHFFFAOYSA-N ac1lavbc Chemical compound [W].[W] WIGAYVXYNSVZAV-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
201000008937 atopic dermatitis Diseases 0.000 description 1
239000011805 ball Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
208000024330 bloating Diseases 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
229910052793 cadmium Inorganic materials 0.000 description 1
BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
230000009702 cancer cell proliferation Effects 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
229910010293 ceramic material Inorganic materials 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000010411 cooking Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000005284 excitation Effects 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000035876 healing Effects 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
DZNKOAWEHDKBEP-UHFFFAOYSA-N methyl 2-[6-[bis(2-methoxy-2-oxoethyl)amino]-5-[2-[2-[bis(2-methoxy-2-oxoethyl)amino]-5-methylphenoxy]ethoxy]-1-benzofuran-2-yl]-1,3-oxazole-5-carboxylate Chemical compound COC(=O)CN(CC(=O)OC)C1=CC=C(C)C=C1OCCOC(C(=C1)N(CC(=O)OC)CC(=O)OC)=CC2=C1OC(C=1OC(=CN=1)C(=O)OC)=C2 DZNKOAWEHDKBEP-UHFFFAOYSA-N 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
238000000465 moulding Methods 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
235000014214 soft drink Nutrition 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
201000005060 thrombophlebitis Diseases 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H33/00—Bathing devices for special therapeutic or hygienic purposes
- A61H33/04—Appliances for sand, mud, wax or foam baths; Appliances for metal baths, e.g. using metal salt solutions
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/29—Mineral substances, e.g. mineral oils or clays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H33/00—Bathing devices for special therapeutic or hygienic purposes
- A61H33/04—Appliances for sand, mud, wax or foam baths; Appliances for metal baths, e.g. using metal salt solutions
- A61H2033/041—Baths with dry sand or other dry particles

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Mycology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Dispersion Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Alternative & Traditional Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Rehabilitation Therapy (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Toxicology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Radiation-Therapy Devices (AREA)
Compositions Of Oxide Ceramics (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

NL1004878A 1995-12-25 1996-12-23 Ver-infrarood stralend materiaal en daarvan vervaardigd geneesmiddel en voedselprodukt alsmede een werkwijze voor het vervaardigen ervan. NL1004878C2 (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP7337559A JPH09173479A (ja)	1995-12-25	1995-12-25	遠赤外線放射体およびそれを用いた医薬品ならびに食品
JP33755995		1995-12-25

Publications (2)

Publication Number	Publication Date
NL1004878A1 NL1004878A1 (nl)	1997-07-02
NL1004878C2 true NL1004878C2 (nl)	1998-03-06

Family

ID=18309788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL1004878A NL1004878C2 (nl)	1995-12-25	1996-12-23	Ver-infrarood stralend materiaal en daarvan vervaardigd geneesmiddel en voedselprodukt alsmede een werkwijze voor het vervaardigen ervan.

Country Status (18)

Country	Link
US (1)	US6004588A (it)
JP (1)	JPH09173479A (it)
KR (1)	KR970042407A (it)
CN (1)	CN1157178A (it)
AU (1)	AU727635B2 (it)
BE (1)	BE1010468A5 (it)
CA (1)	CA2193587A1 (it)
CH (1)	CH691025A5 (it)
DE (1)	DE19654232A1 (it)
DK (1)	DK143596A (it)
ES (1)	ES2124669B1 (it)
FR (1)	FR2742739B1 (it)
GB (1)	GB2308591B (it)
IS (1)	IS4400A (it)
IT (1)	IT1304596B1 (it)
NL (1)	NL1004878C2 (it)
NO (1)	NO965449L (it)
SE (1)	SE508589C2 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100471359B1 (ko) *	2000-12-28	2005-03-07	주식회사 태평양	결정성 무기광물을 함유한 피부 외용제 조성물
US6585896B2 (en)	2001-03-09	2003-07-01	Leon M. Silverstone	Methods and apparatus for molecular induction technology to create changes in the energetic characteristics of various materials, and their use in the production of molecular changes in other media
JP2003062093A (ja) *	2001-08-23	2003-03-04	Koichi Imai	粉状遠赤外線放射体及びその製造方法
CN1229473C (zh) *	2002-01-21	2005-11-30	孙相浩	远红外线辐射体及其制造方法
JP2004107549A (ja) *	2002-09-20	2004-04-08	Toshiyuki Waratani	接着剤
US20050171584A1 (en) *	2004-02-02	2005-08-04	Slingo Fred M.	Heating devices and apparatuses employing far infrared radiation and negative ions
US20050278006A1 (en) *	2004-06-10	2005-12-15	Yoshiaki Omura	Solar energy stored papers and their clinical applications
US20060229691A1 (en) *	2005-04-08	2006-10-12	Noskov Alexander G	System and method of applying a therapeutic treatment
JP2007195759A (ja) *	2006-01-26	2007-08-09	Kikuji Yamashita	癌を予防あるいは治療する住空間
US20090171423A1 (en) *	2006-03-17	2009-07-02	Fukuma Wada	Head Orthosis
WO2012156805A1 (fr) *	2011-05-18	2012-11-22	Rhodia Poliamida E Especialidades Ltda	Fils, fibres ou filaments comprenant des charges minerales; article textile dispositif medical obtenus a partir desdits fils pour la cicatrisation de la peau
CN103919802B (zh) *	2013-01-11	2016-09-07	张仁鸿	心血管疾病防治及生物技术保养保健材料
CN103920574B (zh) *	2013-01-11	2017-04-26	张仁鸿	使具有人体远红外线波段的材料微细化的方法
KR20140105640A (ko) *	2013-02-22	2014-09-02	(주)엘지하우시스	복사열을 이용한 자동차용 면상 발열체
WO2017212299A2 (en) *	2016-06-07	2017-12-14	Kunfalvi Gábor	Artificially produced, intense infrared radiation emitting ceramic composites
CN108816447B (zh) *	2018-06-15	2020-04-21	温州医科大学	一种基于分层收集的中药粉碎机及其中药粉碎方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0347197A1 (en) *	1988-06-15	1989-12-20	Takeda Chemical Industries, Ltd.	Sheet material for skin contact medical treatment
JPH0262812A (ja) *	1988-08-29	1990-03-02	Kanebo Ltd	皮膚化粧料
JPH03112849A (ja) *	1989-09-25	1991-05-14	Nariyuki Furuta	遠赤外線放射性粉末、及びその焼結物の製造方法とその使用方法。
CN1094992A (zh) *	1993-05-10	1994-11-16	吴建	稀土远红外功能陶瓷球体的成型工艺
JPH0859488A (ja) *	1994-08-12	1996-03-05	Masatoshi Nakano	健康増進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3724125A1 (de) *	1987-07-21	1989-02-02	Bavaria Cargo Tech	Rollenfoerderbahn
JPH01289423A (ja) *	1988-05-17	1989-11-21	Tomoaki Otsuka	植物生長法
JPH08175863A (ja) *	1994-12-22	1996-07-09	Fuji Giken Kk	焼結組成物及び混合物
US5802846A (en) *	1997-03-31	1998-09-08	Caterpillar Inc.	Exhaust gas recirculation system for an internal combustion engine
JPH10289423A (ja) *	1997-04-10	1998-10-27	Minebea Co Ltd	垂直磁気記録用複合型ヘッドの製造方法

1995
- 1995-12-25 JP JP7337559A patent/JPH09173479A/ja active Pending
1996
- 1996-12-17 DK DK143596A patent/DK143596A/da not_active Application Discontinuation
- 1996-12-18 NO NO965449A patent/NO965449L/no not_active Application Discontinuation
- 1996-12-19 IS IS4400A patent/IS4400A/is unknown
- 1996-12-19 AU AU75480/96A patent/AU727635B2/en not_active Ceased
- 1996-12-19 GB GB9626379A patent/GB2308591B/en not_active Expired - Fee Related
- 1996-12-20 SE SE9604709A patent/SE508589C2/sv not_active IP Right Cessation
- 1996-12-20 CA CA002193587A patent/CA2193587A1/en not_active Abandoned
- 1996-12-20 US US08/770,254 patent/US6004588A/en not_active Expired - Lifetime
- 1996-12-20 IT IT1996TO001061A patent/IT1304596B1/it active
- 1996-12-23 CH CH03169/96A patent/CH691025A5/fr not_active IP Right Cessation
- 1996-12-23 NL NL1004878A patent/NL1004878C2/nl not_active IP Right Cessation
- 1996-12-23 FR FR9615856A patent/FR2742739B1/fr not_active Expired - Fee Related
- 1996-12-23 DE DE19654232A patent/DE19654232A1/de not_active Withdrawn
- 1996-12-23 KR KR1019960070210A patent/KR970042407A/ko not_active Ceased
- 1996-12-24 ES ES009602728A patent/ES2124669B1/es not_active Expired - Fee Related
- 1996-12-24 BE BE9601080A patent/BE1010468A5/fr not_active IP Right Cessation
- 1996-12-24 CN CN96123810A patent/CN1157178A/zh active Pending

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0347197A1 (en) *	1988-06-15	1989-12-20	Takeda Chemical Industries, Ltd.	Sheet material for skin contact medical treatment
JPH0262812A (ja) *	1988-08-29	1990-03-02	Kanebo Ltd	皮膚化粧料
JPH03112849A (ja) *	1989-09-25	1991-05-14	Nariyuki Furuta	遠赤外線放射性粉末、及びその焼結物の製造方法とその使用方法。
CN1094992A (zh) *	1993-05-10	1994-11-16	吴建	稀土远红外功能陶瓷球体的成型工艺
JPH0859488A (ja) *	1994-08-12	1996-03-05	Masatoshi Nakano	健康増進剤

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 113, no. 4, 23 July 1990, Columbus, Ohio, US; abstract no. 29131, MORI, KENJI ET AL: "Skin cosmetics containing ceramics and acidic mucopolysaccharides" XP002029538 *
CHEMICAL ABSTRACTS, vol. 121, no. 5, 1 August 1994, Columbus, Ohio, US; abstract no. 49737, NIWA, YUKIE ET AL: "Anti-cancer effect in vitro and clinical efficacy of a cancer therapeutic containing natural herbs (BG-104), exposed to far infrared-ray heating and fermentation process using Aspergillus oryzae" XP002029539 *
CHEMICAL ABSTRACTS, vol. 123, no. 20, 13 November 1995, Columbus, Ohio, US; abstract no. 264224, WU, JIAN: "Manufacture of rare-earth far-IR functional ceramic balls" XP002029540 *
CHEMICAL ABSTRACTS, vol. 124, no. 24, 10 June 1996, Columbus, Ohio, US; abstract no. 325018, NAKANO, MASATOSHI ET AL: "Bath preparations containing radiation-emiting feldspar-type minerals for disease control" XP002029537 *
DATABASE MEDLINE XP002040669 *
NIWA Y. ET AL.: "ELECTROMAGNETIC WAVE EMITTING PRODUCTS AND "KIKOH" POTENTIATE HUMAN LEUCOCYTE FUNCTIONS.", INT. J. OF BIOMETEOROLOGY, vol. 37, no. 3, September 1993 (1993-09-01), pages 133 - 138 *
OYO YAKURI (1994), 47(5), 465-77 CODEN: OYYAA2;ISSN: 0300-8533, 1994 *
PATENT ABSTRACTS OF JAPAN vol. 015, no. 302 (C - 0855) 2 August 1991 (1991-08-02) *

Also Published As

Publication number	Publication date
CA2193587A1 (en)	1997-06-26
CH691025A5 (fr)	2001-04-12
JPH09173479A (ja)	1997-07-08
NL1004878A1 (nl)	1997-07-02
IT1304596B1 (it)	2001-03-19
SE508589C3 (it)	1998-11-09
BE1010468A5 (fr)	1998-09-01
FR2742739A1 (fr)	1997-06-27
SE9604709D0 (sv)	1996-12-20
IS4400A (is)	1997-06-26
NO965449L (no)	1997-06-26
SE9604709L (sv)	1997-06-26
NO965449D0 (no)	1996-12-18
US6004588A (en)	1999-12-21
GB2308591B (en)	2000-01-19
KR970042407A (ko)	1997-07-24
GB9626379D0 (en)	1997-02-05
FR2742739B1 (fr)	1998-09-25
AU7548096A (en)	1997-07-03
SE508589C2 (sv)	1998-10-19
ES2124669A1 (es)	1999-02-01
CN1157178A (zh)	1997-08-20
GB2308591A (en)	1997-07-02
AU727635B2 (en)	2000-12-14
ES2124669B1 (es)	1999-11-16
DE19654232A1 (de)	1997-06-26
ITTO961061A1 (it)	1998-06-20
DK143596A (da)	1997-06-26

Legal Events

Date	Code	Title	Description
1997-09-01	AD1A	A request for search or an international type search has been filed
1998-05-06	PD2B	A search report has been drawn up
2008-09-01	VD1	Lapsed due to non-payment of the annual fee	Effective date: 20080701

Publication	Publication Date	Title
Wang et al.	2019	Psoralen protects chondrocytes, exhibits anti-inflammatory effects on synoviocytes, and attenuates monosodium iodoacetate-induced osteoarthritis
Wentworth Jr et al.	2001	Antibody catalysis of the oxidation of water
Godar	1999	Light and death: photons and apoptosis
Lankerani et al.	2004	Photosensitivity to exogenous agents
US6004588A (en)	1999-12-21	Far-infrared radiation material
Takigawa et al.	1982	Mechanisms of contact photosensitivity in mice: I. T cell regulation of contact photosensitivity to tetrachlorosalicylanilide under the genetic restrictions of the major histocompatibility complex
Delaney et al.	2001	Immunotoxicity of a standardized citrus polymethoxylated flavone extract
RU2161955C1 (ru)	2001-01-20	Способ изменения физико-химических или физико-химических и биологических свойств вещества
Takematsu et al.	1986	Interleukin-1-like activity in horny layer extracts: decreased activity in scale extracts of psoriasis and sterile pustular dermatoses
Suarez et al.	1990	Bullous photosensitivity to naproxen:“pseudoporphyria”
El‐Ghorr et al.	1995	The effect of chronic low‐dose UVB radiation on Langerhans cells, sunburn cells, urocanic acid isomers, contact hypersensitivity and serum immunoglobulins in mice
Daniels et al.	1968	Sunburn
Tan et al.	1970	Action spectrum of ultraviolet light-induced damage to nuclear DNA in vivo
Cripps et al.	1971	Xeroderma pigmentosum: abnormal monochromatic action spectrum and autoradiographic studies
Szabó et al.	1981	Coexistent atypical bullous pemphigoid and systemic lupus erythematosus
Izadi et al.	2024	Unveiling of the anti-tumor activity of green synthesized zinc nanoparticles against Ehrlich solid tumors in mice
Horio	1984	Photoallergic Reaction.
Vinay et al.	2013	Pemphigus occurring at tuberculin injection site: role of cytokines in acantholysis
Thurston et al.	1982	Experimental induction of C cell tumours in thyroid by increased dietary content of vitamin D3
Omer et al.	2021	Gum Arabic-induced oral photoprotection: Shifting the balance against circulating immune suppressive cytokines
Sharma et al.	2003	A comparative study of PUVASOL therapy in lichen planus
Ring et al.	1989	Ultraviolet A inhibits histamine release from human peripheral leukocytes
Maksoodan et al.	1989	Studies on testicular regenertive potential of naga bhasma
Serrou et al.	1980	Phase I evaluation of Bestatin in patients bearing advanced solid tumors
Fina et al.	2015	Effect of fluoride on bone metabolism, structure and remodeling